Register
Login:
Share:
Email Facebook Twitter

Is the Bull Market over? Andre Minassian says no! Watch here

Is the Bull Market over? Andre Minassian says no!


Shire Share Chat (SHP)



Share Price: 4,393.00Bid: 4,393.00Ask: 4,394.50Change: -90.50 (-2.02%)Faller - Shire
Spread: 1.50Spread as %: 0.03%Open: 4,451.00High: 4,473.50Low: 4,393.00Yesterday’s Close: 4,483.50


Share Discussion for Shire


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

1
Next Shire Share Chat Page

Dinoken
Posts: 143
Off Topic
Opinion:No Opinion
Price:4,393.00
Foot and Trump
Fri 17:26
Is recent fine for misselling of diabetic foot ulcer treatment just the tip of the iceberg and/or is sp decline down to Trump tweets ? Further to go (down) ?
 
Hankmarvin
Posts: 1,141
Off Topic
Opinion:No Opinion
Price:4,624.50
RE: SHP
13 Jan '17
It will say on your quote if you are
DenFos
Posts: 23
Off Topic
Opinion:No Opinion
Price:4,503.00
SHP
15 Dec '16
Would I pay Stamp Duty if I bought these shares? Ta
Pipk
Posts: 294
Off Topic
Opinion:No Opinion
Price:4,432.50
Takeover
9 Dec '16
At this price looks well placed for takeover, if not then 5000 looks highly likely come Spring.
samadhi1978
Posts: 439
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:4,989.00
Profit taking
3 Aug '16
will bounce back soon!
JR710
Posts: 654
Off Topic
Opinion:No Opinion
Price:4,289.00
The Petition is gaining support
30 May '16
Apologies for board hopping but-
The petition is going quite well; ~5150 signatures so far. Although it really needs a turbo boost.

https://petition.parliament.uk/petitions/112044/sponsors/frRbCOsOLO6QqIN82UOX

This petition was stalled in parliament since 12th Aug 15; finally green lit on 12th feb 2016.
The FCA don't even reply on the matter, now is your chance to have your say.
If you hate seeing buys reported as sells etc!!!!!!
Has already been sent to Martin Lewis, Daily Mail, Moneyweek & Watchdog.

My local MP supported this petition by writing to the petitions committee to help un-stall it.
There’s 650 MP’s in Westminster, So have you written to your MP? 649 to go!

If this petition doesn’t reach 10,000; then imo we might as well have not bothered as it will almost certainly be filed B1N; @ 10,000 the government should respond. We are currently getting approx. 100 new signatures a week, but need 3x that amount to reach the target with only 15 weeks to go.

So – If you haven’t yet signed or indeed have but haven’t passed it on to others, then now’s the time to do so. If each person who has signed can get just one other person to sign then we will double the total immediately. I have posted to all aim listed gas n oilies, currently doing the footsy 100. But I can only do so much to push this. Really need you guys & gals to help. Thanks to all who have signed so far.
faramog
Posts: 254
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
faramog
Posts: 254
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
mrcautious
Posts: 628
Off Topic
Opinion:No Opinion
Price:4,065.00
Great Potential
5 Apr '16
I have a position in this in my SIPP and trading account, it is still a gift
Rhambo
Posts: 1,777
Off Topic
Opinion:No Opinion
Price:3,634.00
RE: Momentum on Shire (SHP)
18 Mar '16
Looks like there is value in this at these levels.
1
Next Shire Share Chat Page




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.